National Cancer Institute; Notice of Closed Meetings, 577 [2010-33285]
Download as PDF
<![CDATA[
jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 3 / Wednesday, January 5, 2011 / Notices
Nanotechnology Therapeutics and
Theranostics.
Date: March 3, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Savvas C Makrides, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Rm 8050a, Bethesda,
MD 20892, 301–496–7421,
makridessc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Development of Blood-based Methods for the
Detection of Cancer Recurrence in PostTherapy Breast Cancer Patients.
Date: March 3, 2011.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 703, Rockville,
MD 20852, (Telephone Conference Call)
Contact Person: Lalita D. Palekar, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7141, Bethesda,
MD 20892, 301–496–7575,
palekarl@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; High Level
Programming Language to Expedite
Development of User Interfaces.
Date: March 8, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 607, Rockville,
MD 20852, (Telephone Conference Call)
Contact Person: Marvin L. Salin, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7073,
Bethesda, MD 20892–8329, 301–496–0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NonCoding RNAs and Cancer.
Date: March 10, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Thomas M Vollberg, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7142, Bethesda,
MD 20892, 301–594–9582,
vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Health
Information Technology to Facilitate PatientCentered Communication in Cancer Related
Care.
Date: March 10, 2011.
Time: 12 p.m. to 3 p.m.
VerDate Mar<15>2010
16:26 Jan 04, 2011
Jkt 223001
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 607, Rockville,
MD 20852, (Telephone Conference Call)
Contact Person: Marvin L. Salin, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7073,
Bethesda, MD 20892–8329, 301–496–0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; MultiCenter Clinical Trials.
Date: March 14, 2011.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 8103, Rockville,
MD 20852, (Telephone Conference Call)
Contact Person: Timothy C. Meeker, M.D.,
PhD, Scientific Review Officer, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8103, Bethesda, MD 20892, (301) 594–1279,
meekert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 28, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–33287 Filed 1–4–11; 8:45 am]
BILLING CODE 4140–01–P
577
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Therapeutic Strategies for Cancer.
Date: February 2–4, 2011.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Majed M. Hamawy,
M.B.A., PhD, Scientific Review Officer,
Research Programs Review Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8135, Bethesda, MD 20852, 301–594–
5659, mh101v@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; K99 and
T32 Review.
Date: February 22, 2011.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Sergei Radaev, PhD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8117, Bethesda, MD 20892, 301–435–
5655, sradaev@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 28, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–33285 Filed 1–4–11; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5415–C–20]
Notice of Funding Availability (NOFA)
for HUD’s Fiscal Year 2010; Resident
Opportunity and Self-Sufficiency
(ROSS)—Service Coordinators
Program; Extension of Application Due
Date
Office of the Assistant
Secretary for Public and Indian
Housing, HUD.
ACTION: Notice of Funding Availability
for HUD’s Fiscal Year (FY) 2010
Resident Opportunity and SelfSufficiency (ROSS) Service
Coordinators Program; Extension of
Application Due Date.
AGENCY:
E:\FR\FM\05JAN1.SGM
05JAN1
]]>Agencies
[Federal Register Volume 76, Number 3 (Wednesday, January 5, 2011)]
[Notices]
[Page 577]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-33285]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Therapeutic Strategies for Cancer.
Date: February 2-4, 2011.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Majed M. Hamawy, M.B.A., PhD, Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 8135, Bethesda, MD 20852, 301-594-5659,
mh101v@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; K99 and T32 Review.
Date: February 22, 2011.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Sergei Radaev, PhD, Scientific Review Officer,
Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 8117, Bethesda, MD 20892, 301-435-5655,
sradaev@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 28, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-33285 Filed 1-4-11; 8:45 am]
BILLING CODE 4140-01-P
